• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>GMO Quality III

GMO Quality III

  1. All
  2. Morningstar Articles
  3. Investing
  4. Research
  1. Investors Are Fleeing These 3 Funds, but Should They?

    Weak relative performance has spurred outflows.

  2. Investors Are Fleeing These 3 Funds, but Should They?

    Weak relative performance has spurred outflows.

  3. Another Buffett-in-a-Box?

    A new iShares fund applies a "quality" strategy to U.S. stocks in an attempt to capture a tiny bit of Warren Buffett's magic.

  4. Which Funds Top Readers' Wishlists?

    Small- and mid-cap holdings top readers' lists of attractive funds that are closed or otherwise unavailable.

  5. How Actively Managed Are Some of the Biggest Large-Blend Funds?

    Using the active share metric, we examine the degree to which these funds' portfolios differ from the benchmark.

  6. Funds Betting on Big Pharma

    Large drugmakers are out of favor, but some good funds are banking on a rebound.

  7. Fund Moat Ratings and the Bear Market

    Wide-moat funds were the stars of the recent downturn.

  8. An American Funds Bond Fund Gains 2 New Comanagers

    Plus, USAA jettisons GMO on USAA Income Stock, and a new comanager on Gold-rated Jensen Quality Growth.

  9. Chuck Joyce Steps Down From GMO Quality

    Joyce is also set to leave GMO. Also, American Century's LIVESTRONG funds withstand Lance Armstrong controversy, Dreyfus' CEO departs, manager changes at Fidelity and American Century, and analyst reductions at UBS Global Asset Management.

  10. Might Makes Right

    The market has rarely discounted large, strong companies this cheaply, argue Steven Romick of FPA and Ben Inker of GMO.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.